8:39 PM
 | 
Jan 07, 2019
 |  BC Extra  |  Financial News

Alector, Poseida and Anchiano propose NASDAQ listings

Editor's Note: This article was updated on Jan 08, 2019 at 1:09 PM PST

Alector Inc. (South San Francisco, Calif.), Poseida Therapeutics Inc. (San Diego, Calif.) and Anchiano Therapeutics Inc. (Tel Aviv:ANCN) have proposed to list on NASDAQ.

Alector, which aims to target immune dysfunction to treat neurodegenerative disorders, is seeking up to $150 million in an IPO. In July 2018, the company raised $133 million in series E funding to develop antibodies designed to boost microglial-mediated clearance of disease-associated proteins from the brain. Two of its antibodies with undisclosed targets have reached Phase I testing: AL001...

Read the full 392 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >